Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMC 548173)

Published in BMJ on January 28, 2005

Authors

P Vineis1, L Airoldi, F Veglia, L Olgiati, R Pastorelli, H Autrup, A Dunning, S Garte, E Gormally, P Hainaut, C Malaveille, G Matullo, M Peluso, K Overvad, A Tjonneland, F Clavel-Chapelon, H Boeing, V Krogh, D Palli, S Panico, R Tumino, B Bueno-De-Mesquita, P Peeters, G Berglund, G Hallmans, R Saracci, E Riboli

Author Affiliations

1: Imperial College, London W2 1PG. p.vineis@imperial.ac.uk

Articles citing this

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94

Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect (2006) 4.04

Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer (2007) 1.70

Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65

Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med (2010) 1.48

2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer (2011) 1.45

Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect (2012) 1.44

Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke. BMC Public Health (2015) 1.42

Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health (2007) 1.41

Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study. BMJ (2006) 1.34

The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health (2009) 1.31

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer (2013) 1.31

Hookah (Shisha, Narghile) Smoking and Environmental Tobacco Smoke (ETS). A critical review of the relevant literature and the public health consequences. Int J Environ Res Public Health (2009) 1.30

Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat Res (2010) 1.30

Decline in respiratory symptoms in service workers five months after a public smoking ban. Tob Control (2006) 1.27

More evidence on the risks of passive smoking. BMJ (2005) 1.20

Traffic related air pollution as a determinant of asthma among Taiwanese school children. Thorax (2005) 1.19

Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.04

Correlates of exposure to second-hand smoke in an urban Mediterranean population. BMC Public Health (2007) 1.00

Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci (2014) 0.98

Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer (2014) 0.95

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. PLoS One (2013) 0.92

The economic impact of early life environmental tobacco smoke exposure: early intervention for developmental delay. Environ Health Perspect (2006) 0.91

Assessment of interindividual and geographic variability in human exposure to fine particulate matter in environmental tobacco smoke. Risk Anal (2010) 0.91

Environmental tobacco smoke and laryngeal cancer: results from a population-based case-control study. Eur Arch Otorhinolaryngol (2008) 0.90

Individual rights advocacy in tobacco control policies: an assessment and recommendation. Tob Control (2005) 0.89

Childhood passive smoke exposure is associated with adult head and neck cancer. Cancer Epidemiol (2013) 0.86

A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood. Cancer Prev Res (Phila) (2014) 0.86

Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes. Cancer Epidemiol Biomarkers Prev (2011) 0.85

Prevalence and Predictors of Environmental Tobacco Smoke Exposure among Adolescents in Cambodia. Indian J Community Med (2010) 0.85

Childhood and adult secondhand smoke and type 2 diabetes in women. Diabetes Care (2013) 0.83

"Smoking in Children's Environment Test": a qualitative study of experiences of a new instrument applied in preventive work in child health care. BMC Pediatr (2011) 0.82

Maternal smoking and the retinoid pathway in the developing lung. Respir Res (2012) 0.82

Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health (2010) 0.81

Recent contributions of air- and biomarkers to the control of secondhand smoke (SHS): a review. Int J Environ Res Public Health (2011) 0.81

Analysis of the transcriptome in molecular epidemiology studies. Environ Mol Mutagen (2013) 0.79

Cetuximab and biomarkers in non-small-cell lung carcinoma. Biologics (2012) 0.79

Respiratory effects of environmental tobacco exposure are enhanced by bronchial hyperreactivity. Am J Respir Crit Care Med (2006) 0.78

Quantification of ETS exposure in hospitality workers who have never smoked. Environ Health (2010) 0.78

Association Between Exposure to Environmental Tobacco Smoke at the Workplace and Risk for Developing a Colorectal Adenoma: A Cross-Sectional Study. Ann Coloproctol (2016) 0.77

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomark Insights (2016) 0.76

Evaluation of the Modeling of Exposure to Environmental Tobacco Smoke (ETS) in the SHEDS-PM Model. Proc Air Waste Manage Assoc Meet (2009) 0.75

Timing of cigarette smoking as a risk factor for multiple sclerosis. Ther Adv Neurol Disord (2013) 0.75

Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Environmental Tobacco Smoke Exposure and Smoke-Free Rules in Homes among Socially-Disadvantaged Populations in Poland. Int J Environ Res Public Health (2017) 0.75

Cancer incidence attributable to tobacco in Alberta, Canada, in 2012. CMAJ Open (2016) 0.75

MODELING OF HUMAN EXPOSURE TO IN-VEHICLE PM(2.5) FROM ENVIRONMENTAL TOBACCO SMOKE. Hum Ecol Risk Assess (2012) 0.75

Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. Toxicol Rep (2015) 0.75

Articles cited by this

Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum (2004) 14.27

Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ (1997) 8.05

Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol (2004) 5.07

Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83

Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect (1999) 3.50

Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst (1999) 2.83

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev (2001) 1.41

Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. Int J Epidemiol (2000) 1.38

Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinat Epidemiol (1994) 1.14

Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev (2000) 1.09

Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer (2003) 1.07

Articles by these authors

General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA (1994) 6.00

Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control (2008) 4.37

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene (2007) 4.27

A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11

End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries. EURONIC Study Group. Lancet (2000) 4.01

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78

Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57

Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43

Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35

Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed (1999) 3.14

Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79

Directive of the European Parliament and of the council on the protection of individuals with regard to the processing of personal data and on the free movement of such data. The International Epidemiological Association-IEA European Epidemiological Group. Int J Epidemiol (1995) 2.77

The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev (2001) 2.72

Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care (2000) 2.63

Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (1999) 2.63

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59

Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer (1977) 2.59

Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57

The IDEFICS cohort: design, characteristics and participation in the baseline survey. Int J Obes (Lond) (2011) 2.54

Effect of alcohol consumption on systemic markers of inflammation. Lancet (2001) 2.52

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics (1992) 2.45

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J (1998) 2.38

Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr (2001) 2.37

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis (2005) 2.35

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34

Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (1976) 2.34

Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis (1992) 2.31

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25

Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23

Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 2.23

European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr (2002) 2.23

Should euthanasia be legal? An international survey of neonatal intensive care units staff. Arch Dis Child Fetal Neonatal Ed (2004) 2.21

The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21

Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J (2010) 2.20

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20